Lenacapavir 463.5mg/1.5ml solution for injection vials
- SNOMED code
45160711000001109- Active compound
- Lenacapavir
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 1.5 ml, vial
- Ingredients
- Lenacapavir sodium, ID: 1351588006
— 309 mg
/ 1 ml
based on base substance
- Form & Route
- solutioninjection.subcutaneous
Solution for injection, Subcutaneous - Controlled drug
- No Controlled Drug Status
Products
Sunlenca 464mg/1.5ml solution for injection vials (Gilead Sciences Ltd)
Sunlenca 464mg/1.5ml solution for injection vials
- SNOMED code
45153111000001109- Supplier
- Gilead Sciences Ltd
- Licensed as
- Medicines - MHRA/EMA
- EMA (European Medicines Agency) Monitoring
- ▼ Yes, black triangle marked
- Availability restrictions
- None
- Licensed route
- Subcutaneous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Sunlenca 464mg/1.5ml solution for injection vials (Gilead Sciences Ltd) 2 vial45153211000001103 ref. pack | 💯 Available Legal category: POM | 539150714751605391507147516 | NHS Indicative Price £17,653 | • Hospital |
| — |
Reference packs
Lenacapavir 463.5mg/1.5ml solution for injection vials 2 vial
- SNOMED code
45153011000001108- Quantity and unit
- 2 vial
- Packs